• Home
  • Research
  • Our Scientific Partnerships & Collaborations

Our Scientific Partnerships & Collaborations

At Human Technopole we are committed to improving people’s health and wellbeing through a multidisciplinary and integrated approach to life science research, including through partnerships and collaborations with other national and international research institutions. Since our early days of activity, we have been engaging with Universities, research hospitals and other scientific organisations to explore synergies and promote joint collaborative initiatives.

Our scientific partnerships and collaborations are based on shared scientific interests and common research questions, as well as on complementarity in research skills, methods and expertise.

If you are interested in learning more about our scientific partnerships and collaborations or for more information on our activity, you can get in touch with Cristina Letizia.



Human Technopole establishes collaborative relationships and supports long-term scientific cooperation with a variety of scientific organisations through Memoranda of Understanding (MoU) – general agreements for the development of joint research or training initiatives in areas of common interest. HT has signed MoUs with the following organisations:


Human Technopole collaborates with a variety of research partners for the development of specific projects. Such collaborations are formalised through Research Collaboration Agreements (RCAs). HT has signed RCAs for the following projects:

  • Multiomics analysis and population stratification to study COVID-19 epidemiology in the Vò municipality with Università di Padova, Department of Molecular Medicine
  • Multiomics analysis and population stratification to study COVID-19 epidemiology in the Padua municipality with Università di Padova, Department of Biomedical Sciences.
  • Powered genetic studies of medically relevant traits in the Moli-sani study with IRCCS Neuromed.
  • High throughput brain organoid longitudinal profiling from the Italian cohort of neurodevelopmental disorders with IRCCS Oasi Maria Santissima
  • Prospective study to investigate tumor biology and therapy resistance factors by liquid biopsy and patient derived organoids (PDO) in patients with gastrointestinal tract, bilio-pancreatic, neuroendocrine tumors and Merkel cell carcinomas with IRCCS Istituto Nazionale Tumori
  • Genome-wide prediction of oncology targets and in silico drug prescriptions using functional genomics and patient data, with Wellcome Sanger Institute (UK)
  • Identification of genetic determinants of the predisposition to develop respiratory failure in persons infected by SARS-CoV-2 (FOGS), with Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico
  • Large-Scale profiling of the plasma proteome in diverse cohorts, with University of Cambridge (UK)
  • Comprehensive mapping regulatory elements and interactomes in human samples, with Riken (Japan)
  • Characterisation of RNA function in mammalian biology, with Riken (Japan)
  • Cancer computational genomics and evolution with bulk and single-cell sequencing, with Università degli Studi di Trieste
  • Phenotypic mapping of gene functions in immune cells, with Wellcome Sanger Institute (UK)
  • Identification of genetic and gene-environment resilience and risk factors for neurodevelopmental outcomes in children with Karlstad University (Sweden)
  • Using proteomics in systems genomics approaches to elucidate pathophysiological mechanisms of cardiovascular diseases with Eurac Research
  • Functional annotation of human non-coding RNAs with Fantom 6, Riken (Japan)


Human Technopole builds links with and participates in European and international large-scale collaborative research endeavours and consortia.